Top compounds associated with response to CT47A7


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA PD318088 CTRPv2 pan-cancer AAC -0.086 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.01
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.01
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.01
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.083 0.01
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.079 0.02
Download CSV